Nicholas Lodato
Principal Scientist, Pillar Biosciences
Dr. Nicholas Lodato is a Principal Scientist at Pillar Biosciences and has spent the last seven years developing new amplicon-based targeted panels for the detection of low-frequency variants in circulating cell free DNA and solid tumors, including the FDA-approved oncoReveal Dx Lung and Colon Cancer Assay. He received his Ph.D. in Cell and Molecular Biology at Boston University, where he researched epigenetic mechanisms of gene regulation and liver disease using mouse models.